
Invest in the Best
Check two-year estimates on Price, Revenue & Earnings
| Open | 546.55 |
| High | 559.00 |
| Low | 530.00 |
| Prev Close | 547.95 |
| Volume | 3,36,527 |
| VWAP(₹) | 542.91 |
| PE Ratio(x) | 52.01 |
| EPS - TTM(₹) | 10.24 |
| MCap(₹ Cr.) | 8,480.33 |
| MCap Rank | 18 |
| PB Ratio(x) | 14.88 |
| Div Yield(%) | 2.63 |
| Face Value(₹) | 10.00 |
| 52W High(₹) | 578.25 |
| 52W Low(₹) | 316.78 |
| MCap/Sales | 6.71 |
| Beta(1 Month) | 0.58 |
| BV/Share(₹) | 36.82 |
Dividend Announcement
Company announced a dividend of Rs 7.0 per share on May 7, 2026 with record date of Jun 23, 2026.ROE Outperforming 5 Year Average
Company delivered ROE of 27.84% in year ending Mar 31, 2026 outperforming its 5 year avg. of 20.8%. (Source: Consolidated Financials)Beating 3 Yr Revenue CAGR
Company's annual revenue growth of 20.49% outperformed its 3 year CAGR of 16.32%. (Source: Consolidated Financials)Employee & Interest Expense
Company has spent less than 1% of its operating revenues towards interest expenses and 16.65% towards employee cost in the year ending Mar 31, 2026. (Source: Consolidated Financials)Thyrocare Tech. Share Price Update
Thyrocare Technologies Ltd. share price moved down by -2.77% from its previous close of Rs 547.95. Thyrocare Technologies Ltd. stock last traded price is 532.80
| Share Price | Value |
|---|---|
| Today/Current/Last | 532.80 |
| Previous Day | 547.95 |
Found Insights useful?
| 1 Day | -2.77% |
| 1 Month | 9.52% |
| 3 Months | 42.35% |
| 1 Year | 60.61% |
| 3 Years | 240.27% |
| 5 Years | 43.44% |
4 Analysts
| Ratings | Current | 1W Ago | 1M Ago | 3M Ago |
|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 |
| Buy | 2 | 2 | 1 | 1 |
| Hold | - | - | - | - |
| Sell | - | - | - | - |
| Strong Sell | - | - | - | - |
| # Analysts | 4 | 4 | 3 | 3 |
| Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | |
|---|---|---|---|---|---|
| Total Income | 200.51 | 219.58 | 197.68 | 191.75 | 169.93 |
| Total Income Growth (%) | -8.68 | 11.08 | 3.09 | 12.84 | -5.57 |
| Total Expenses | 165.49 | 156.69 | 146.67 | 143.23 | 141.25 |
| Total Expenses Growth (%) | 5.62 | 6.83 | 2.40 | 1.40 | -0.63 |
| EBIT | 35.02 | 62.89 | 51.01 | 48.52 | 28.68 |
| EBIT Growth (%) | -44.32 | 23.29 | 5.13 | 69.18 | -24.17 |
| Profit after Tax (PAT) | 29.01 | 47.99 | 38.93 | 21.70 | 19.11 |
| PAT Growth (%) | -39.55 | 23.27 | 79.40 | 13.55 | -28.35 |
| EBIT Margin (%) | 17.47 | 28.64 | 25.80 | 25.30 | 16.88 |
| Net Profit Margin (%) | 14.47 | 21.86 | 19.69 | 11.32 | 11.25 |
| Basic EPS (₹) | 1.82 | 9.05 | 7.35 | 4.17 | 3.58 |
All figures in Rs Cr, unless mentioned otherwise
Beating 3 Yr Revenue CAGR
Company's annual revenue growth of 20.49% outperformed its 3 year CAGR of 16.32%. (Source: Consolidated Financials)Employee & Interest Expense
Company has spent less than 1% of its operating revenues towards interest expenses and 16.65% towards employee cost in the year ending Mar 31, 2026. (Source: Consolidated Financials)| Annual | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Total Assets | 692.75 | 643.88 | 632.72 | 607.66 | 545.80 |
| Total Assets Growth (%) | 7.59 | 1.76 | 4.12 | 11.33 | 15.91 |
| Total Liabilities | 145.70 | 116.25 | 97.50 | 81.09 | 118.53 |
| Total Liabilities Growth (%) | 25.33 | 19.23 | 20.24 | -31.59 | 13.71 |
| Total Equity | 547.05 | 527.63 | 535.22 | 526.57 | 427.27 |
| Total Equity Growth (%) | 3.68 | -1.42 | 1.64 | 23.24 | 16.54 |
| Current Ratio (x) | 2.77 | 3.08 | 3.54 | 4.19 | 2.50 |
| Total Debt to Equity (x) | 0.00 | 0.04 | 0.00 | 0.00 | 0.00 |
| Contingent Liabilities | 216.83 | 299.65 | 404.97 | 156.92 | 129.81 |
All figures in Rs Cr, unless mentioned otherwise
| Annual | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Net Cash flow from Operating Activities | 191.32 | 167.63 | 129.31 | 113.41 | 116.03 |
| Net Cash used in Investing Activities | -52.52 | -91.28 | -38.99 | -23.57 | -50.23 |
| Net Cash flow from Financing Activities | -130.42 | -84.81 | -86.18 | -89.41 | -61.56 |
| Net Cash Flow | 8.38 | -8.46 | 4.14 | 0.43 | 4.24 |
| Closing Cash & Cash Equivalent | 17.68 | 9.30 | 17.77 | 13.63 | 13.20 |
| Closing Cash & Cash Equivalent Growth (%) | 90.11 | -47.66 | 30.37 | 3.26 | 47.32 |
| Total Debt/ CFO (x) | 0.00 | 0.13 | 0.00 | 0.00 | 0.00 |
All figures in Rs Cr, unless mentioned otherwise
Decrease in Cash from Investing
Company has used Rs 23.01 cr for investing activities which is an YoY decrease of 56.19%. (Source: Consolidated Financials)| Annual | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Return on Equity (%) | 16.73 | 13.43 | 12.04 | 33.45 | 26.48 |
| Return on Capital Employed (%) | 26.26 | 18.03 | 16.15 | 42.39 | 34.03 |
| Return on Assets (%) | 13.20 | 10.98 | 10.17 | 28.98 | 20.73 |
| Interest Coverage Ratio (x) | 67.28 | 34.95 | 54.67 | 111.45 | 176.33 |
| Asset Turnover Ratio (x) | 1.03 | 0.90 | 0.80 | 0.98 | 90.62 |
| Price to Earnings (x) | 39.53 | 44.44 | 35.46 | 23.26 | 42.19 |
| Price to Book (x) | 6.59 | 5.95 | 4.26 | 7.77 | 11.17 |
| EV/EBITDA (x) | 17.30 | 21.24 | 17.49 | 15.44 | 25.90 |
| EBITDA Margin (%) | 29.85 | 25.66 | 24.39 | 44.85 | 37.13 |
ROE Outperforming 5 Year Average
Company delivered ROE of 27.84% in year ending Mar 31, 2026 outperforming its 5 year avg. of 20.8%. (Source: Consolidated Financials)Found Financials useful?
No Data Available
Global Meltdown1st Jan 2008 to 10th Nov 2008
Covid Crisis1st Feb 2020 to 31st Mar 2020
| R1 | - | Pivot - | S1 | - |
| R2 | - | S2 | - | |
| R3 | - | S3 | - |
| 5 Days | 14 Days | 28 Days |
| - | - | - |
Choose from Peers
Choose from Stocks
MF Ownership as on 30 April 2026
206.87
Amount Invested (in Cr.)
0.28%
% of AUM
0.00
% Change (MoM basis)
176.14
Amount Invested (in Cr.)
2.11%
% of AUM
0.18
% Change (MoM basis)
175.06
Amount Invested (in Cr.)
1.31%
% of AUM
0.00
% Change (MoM basis)
General Meeting
-
Jun 05, 2026
Final
70%
May 07, 2026
Board Meeting
Audited Results & Final Dividend
Apr 29, 2026
| Announced on | Meeting on |
| Apr 29, 2026 | May 07, 2026 |
| Audited Results & Final Dividend | |
| Jan 20, 2026 | Jan 28, 2026 |
| Quarterly Results | |
| Oct 06, 2025 | Oct 14, 2025 |
| Qtr Results, Int. Dividend & Bonus issue | |
| Jul 16, 2025 | Jul 23, 2025 |
| Quarterly Results | |
| Apr 16, 2025 | Apr 23, 2025 |
| Audited Results & Final Dividend | |
| Announced on | Ex-Date | Dividend% |
| May 07, 2026 | Jun 23, 2026 | 70% |
| Oct 14, 2025 | Oct 24, 2025 | 70% |
| Apr 23, 2025 | Jul 25, 2025 | 210% |
| May 14, 2024 | Aug 16, 2024 | 180% |
| Apr 10, 2023 | Apr 20, 2023 | 180% |
| Announced on | Ex-Date |
| Oct 14, 2025 | Nov 28, 2025 |
| Bonus Ratio: 2 share(s) for every 1 shares held | |
No Data Available
No Data Available
| Announced on | Meeting on |
| Jun 05, 2026 | Jun 30, 2026 |
| - | |
| Oct 16, 2025 | Nov 18, 2025 |
| - | |
| Aug 26, 2025 | Sep 28, 2025 |
| - | |
| Jul 07, 2025 | Jul 31, 2025 |
| - | |
| Dec 09, 2024 | Jan 13, 2025 |
| - | |
Thyrocare Technologies Ltd., incorporated in the year 2000, is a Mid Cap company (having a market cap of Rs 8,480.33 Crore) operating in Hospitals & Allied Services sector.
Industry
Key Indices Listed On
BSE SmallCap, BSE Healthcare, BSE AllCap, Nifty Microcap 250, BSE NEXT 500
Address
D/37-1, TTC Industrial Area,MIDC, Turbhe,New Mumbai, Maharashtra - 400703
Rahul Guha
Chairman & M.D & CEOAlok Kumar Jagnani
Non Exe.Non Ind.DirectorGaurav Verma
Non Exe.Non Ind.DirectorUday Patel Kadam
Non Exe.Non Ind.DirectorDATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).
DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.
By using this site, you agree to the Terms of Service and Privacy Policy.